12
New York Oncology Forum By Chinese American Hematologist Oncologist Network 血液与 WWW.CAHON.ORG Conference Chair: Delong Liu, MD, PhD Professor of Medicine, New York Medical College Editorinchief, Journal of Hematology & Oncology Cochairs: Jingzhou Hou, MD, PhD CAHON President Clinical Assistant Professor of Medicine University of Pittsburgh Medical Center Gary Guo, MD, PhD ACAP President, Attending Physician Westchester Medical Center

9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

New  York  Oncology  Forum  By  

Chinese  American  Hematologist  Oncologist  Network    美华血液与肿瘤专家协会  

   

   

WWW.CAHON.ORG    Conference  Chair:    Delong  Liu,  MD,  PhD  Professor  of  Medicine,  New  York  Medical  College  Editor-­‐in-­‐chief,  Journal  of  Hematology  &  Oncology    Co-­‐chairs:  Jingzhou  Hou,  MD,  PhD  CAHON  President  Clinical  Assistant  Professor  of  Medicine    University  of  Pittsburgh  Medical  Center    Gary  Guo,  MD,  PhD  ACAP  President,  Attending  Physician  Westchester  Medical  Center    

Page 2: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

 Organization  Committee    David  Chang,  MD,  PhD,  Associate  Professor,  Eastern  Virginia  Medical  School;  Director,  GI  Oncology,  Virginia  Oncology  Associates,  Virginia  Zili  He,  MD,  PhD,  ACAP  CEO,  Hematology  &  Oncology,  Queens,  NY.    Zihai  Li,  MD,  PhD,  Chairman,  Department  of  Microbiology  &  Immunology,  Medical  University  of  South  Carolina,  Charleston,  SC;  Editor-­‐in-­‐chief,  Experimental  Hematology  &  Oncology  (www.ehoonline.org)  Ke  Liu,  MD,  PhD,  CAHON  Board  member  Wenru  Song  ,MD,  PhD,  CAHON  Board  Chair  Weijing  Sun,  MD,  PhD,  Professor  and  Director  of  GI  Oncology,  University  of  Pittsburgh  Medical  Center,  PA  Michael  Wang,  MD,  Associate  Professor  of  Medicine,  MDACC,  TX  Jeffrey  Ye,  MD,  PhD,  Hematology  &  Oncology,  Kaiser,  CA  Ruirong  Yuan,  MD,  PhD,  Chief  Medical  Officer,  Eisai  Global  Oncology  Richard  Xu,  MD  ,  PhD,  Long  Island  Queens  Hematology  &  Oncology,  CEO  of  Mdland,  NY    Faculties  Lieping  Chen,  MD,  PhD,  Professor,  Yale  University,  New  Haven,  CT  Ping  Chi,  MD,  PhD,  Assistant  Member,  Human  Oncology  and  Pathogenesis  Program  Assistant  Attending  Physician  and  Geoffrey  Beene  Junior  Faculty  Chair  ,  Department  of  Medicine,  Sarcoma  Oncology  Service,  Memorial  Sloan  Kettering  Cancer  Center,  NY  Chau  Dang,  MD,  Breast  Oncology,  Chief  of  MSKCC  Harrison  Branch,  NY  Ping  Gu,  MD,  PhD,  Assistant  Professor  of  Medicine,  NYU  Medical  Center,  NY  Chung-­‐tsen  Hsueh,  MD,  PhD,  Associate  Professor  of  Medicine,  Fellowship  Program  Director  of  Loma  Linda  University,  LA;  Editor-­‐in-­‐chief,  Biomarker  Research  Yiwu  Huang,  MD,  Associate  Professor,  Fellowship  Director,  Maimonides  Med  Center,  NY  Yuxia  Jia,  MD,  PhD,  Assistant  Professor,  Hematology  &  Oncology,  Penn  State  Hershey  Cancer  Institute,  PA  Baoqing  Li,  MD,  Assistant  Professor  of  Radiation  Oncology,  Weill  Cornell  Medical  College,  NY  William  Li,  MD,  Director  of  Radiation  Oncology,  Queens  Hospital  Center,  NY  Tianhong  Li,  MD,  PhD,  Associate  professor,  Hematology  &  Oncology,  UC  Davis,  CA  Zujun  Li,  MD,  Clinical  Associate  Professor,  NYU  Langone  Cancer  Center,  NY  Michael  Liao,  MD,  PhD,  Partner  Oncology,  Puyallup,  WA  Edward  H.  Lin,  MD,  Associate  Professor,  University  of  Washington,  Seattle,  WA  Eric  H.  Liu,  MD,  Co-­‐Director,  Neuroendocrine  Center,  Surgical  Services,  Rocky  Mountain  Cancer  Centers,  Denver,  CO  Hongtao  Liu,  MD,  PhD,  Assistant  Professor,  Hematology  &  Oncology,  University  of  Chicago  Zach  Liu,  MD,  PhD,  Hematopathologist,  Emerge,  NJ  Janice  Lu,  MD,  PhD,  Associate  Professor,  Division of Hematology and Oncology, David Geffen School of Medicine, UCLA,  CA  Shuo  Ma,  MD,  PhD,  Assistant  Professor,  Feinberg  School  of  Medicine,  Northwestern  University,  Chicago,  IL  

Page 3: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

Yupo  Ma,  MD,  PhD,  Professor  of  Pathology,  Director  of  Flowcytometry  Laboratory,  SUNY  Stonybrook  Medical  Center,  NY  Lan  Mo,  MD,  PhD,  Assistant  Professor,  Weill  Cornell  Medical  College,  NY  Max  Ning,  MD,  CAHON  life  member  Jia  Ruan,  MD,  PhD,  Associate  Professor  of  Clinical  Medicine,  Weill  Cornell  Medical  College,  NY  Min  Sun,  MD,  PhD,  Clinical  Assistant  Professor,  University  of  Pittsburgh  Medical  Center,  PA  Mei  Tang,  MD,  Hematology  &  Oncology,  Baltimore,  MD  Che-­‐Kai  Tsao,  MD,  Assistant  Professor,  Tisch  Cancer  Institute,  Mount  Sinai  Medical  Center,  NY  Yifan  Tu,    Assistant  Professor  of  Hematology  &  Oncology,  Saint  Louis  University  Hospital,  MO  Jen  C  Wang  ,  MD,  Associate  Professor  of  Medicine,  SUNY  Downstate,  NY  Jiping  Wang,  MD,  PhD,  Assistant  Professor  of  Surgery,  Harvard  Medical  School,  Boston,  MA  Lihong  Wei,  MD,  Hematology  &  Oncology,  Queens,  NY  Shenhong  Wu,  MD,  PhD,  Clinical  Associate  Professor,  SUNY  Stonybrook  Cancer  Center,  NY  Yiqing  Xu,  MD,  Associate  Professor,  Director  of  Clinical  Research,  Maimonides  Cancer  Center,  NY  Peter  Yu,  MD,  ASCO  immediate-­‐past  president  and  Palo  Alto  Medical  Foundation,  CA  Jianda  Yuan,  PhD,  Memorial  Sloan-­‐Kettering  Cancer  Center,  NY  Lanjing  Zhang,  MD,  PhD.  Director  of  GI  Pathology,  Robert  Wood  Johnson,  NJ  Yue  Zhang,  MD,  MPH,  Assistant  Professor  of  Medicine,  SUNY  Stony  Brook  Cancer  Center,  NY  Sen  Zhuang,  MD,  PhD,  Vice  President,  Clinical  Oncology  Research,  J  &  J    Staff  Xiaohui  Xi        New  York  Oncology  Forum  will  be  hosted  by  Chinese  American  Hematologist  Oncologist  Network  (www.CAHON.org)  in  the  Sheraton  La  Guardia  East  in  Flushing,  New  York  on  October  3,  2015,  Saturday.      The  target  audience  are  clinicians,  nurses,  pharmacists,  medical  students,  clinical  fellows  as  well  as  laboratory  scientists  working  in  the  related  areas.  This  is  an  educational  program.    There  will  be  separate  satellite  symposia  at  lunch  time.  An  exhibition  area  will  be  setup  away  from  the  conference  room  at  the  same  time  for  pharmaceutical  companies,  financial  companies,  pharmacies,  and  commercial  laboratories  to  showcase  their  products  and  services.  There  will  also  be  special  sessions  focusing  on  issues  related  to  clinical  practice,  training,  and  career  paths.    Active  CAHON  members  will  give  presentations  focusing  on  latest  developments  in  the  fields  of  hematology  and  oncology.  Drug  development  and  molecular  diagnosis  will  be  included.  The  learning  objectives  are  (1)  updates  on  novel  agents  and  regimens  for  cancer  diagnosis  and  therapy;  (2)  updates  and  guidance  for  

Page 4: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

molecular  diagnosis,  drug  development,  and  precision  therapy;  (3)  recommendations  and  guidance  on  clinical  training  and  career  paths.      

Page 5: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

 

 October  3,  2015,  Saturday  

7am  -­‐4pm  Sheraton  LaGuardia  East  Hotel  

Phenix  Ballrooms  135-­‐20  39th  Ave,  Flushing,  NY  11354  

   7:00  -­‐9:00       Registration    Plenary  session    Session  chairs:    Wenru  Song,  MD,  PhD,  CAHON  Board  Chair  Zihai  Li,  MD,  PhD,  Chairman,  Department  of  Microbiology  &  Immunology,  Medical  University  of  South  Carolina,  Charleston,  SC;  Editor-­‐in-­‐chief,  Experimental  Hematology  &  Oncology  (www.ehoonline.org)    8:00-­‐8:10     Welcome  Remarks,  CAHON  and  ACAP  Introduction      

Delong  Liu,  MD,  PhD;  Jingzhou  Hou,  MD,  PhD,  CAHON  &  Gary  Guo,  MD,  PhD,  ACAP  

 8:10  -­‐8:45     Future  of  cancer  care  

Peter  Yu,  MD.  Immediate-­‐past  ASCO  president  and  Palo  Alto  Medical  Foundation  

 8:45-­‐9:20     PD-­‐1/PD-­‐L1:  from  discovery  to  clinical  applications         Lieping  Chen,  MD,  PhD,  Professor,  Yale  University            9:20-­‐9:40     Coffee  Break    Simultaneous  sessions    Hematology  and  Oncology    Session  chairs:    Michael  Wang,  MD,  Associate  Professor  of  Medicine,  MDACC  Jen  Chin  Wang,  MD,  Associate  Professor  of  Medicine,  SUNY  Downstate,  NY  Hongtao  Liu,  MD,  PhD,  Assistant  Professor,  University  of  Chicago  

Page 6: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

         9:40  -­‐9:55     Novel  agents  for  myeloproliferative  neoplasm               Hongtao  Liu,  MD,  PhD,  Assistant  Professor,  University  of  Chicago      9:55  -­‐10:10     Novel  agents  for  B  cell  lymphoma  

Michael  Wang,  MD,  Associate  Professor  of  Medicine,  MDACC      10:10  -­‐10:25     Novel  agents  for  T  cell  lymphoma        

Jia  Ruan,  MD,  PhD,  Associate  Professor  of  Clinical  Medicine,  Weill  Cornell  Medical  College,  NY    

 10:25  -­‐10:40     Novel  agents  for  multiple  myeloma        

Jingzhou  Hou,  MD,  PhD,  Clinical  Assistant  Professor  of  Medicine,  University  of  Pittsburgh  Medical  Center,  PA  

   10:40-­‐11:00     Coffee  Break    Session  chairs:    Weijing  Sun,  MD,  PhD,  Professor  of  Medicine,  University  of  Pittsburgh  Medical  Center,  PA  Yiwu  Huang,  MD,  PhD,  Associate  Professor,  Director  of  Fellowship  Program;  Maimonides  Med  Center,  Brooklyn,  NY  Michael  Liao,  MD,  PhD,  Partner  Oncology,  Puyallup,  WA    11:00-­‐11:15     Pancreatic  cancer  update        

David  Chang,  MD,  PhD,  Associate  Professor,  Eastern  Virginia  Medical  School;  Director,  GI  Oncology,  Virginia  Oncology  Associates,  Virginia  

   11:15-­‐11:30     Novel  agents  for  stomach  cancer      

Chung-­‐tsen  Hsueh,  MD,  PhD,  Associate  Professor  of  Medicine,  Fellowship  Program  Director  of  Loma  Linda  University,  LA;  Editor-­‐in-­‐chief,  Biomarker  Research  

         11:30-­‐11:45     Colon  cancer  update         Edward  H.  Lin,  MD,    Associate  Professor,  Univ.  of  Washington,  Seattle    11:45-­‐12:00     Coffee  Break  

Page 7: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

   Simultaneous  sessions    Molecular  Diagnosis  and  Precision  Therapy  Session  chairs:      Ke  Liu,  MD,  PhD.,  CAHON.          Max  Ning,  MD,  NCI;        9:40  -­‐10:10     Next  generation  sequencing    for  clinical  applications      

Zach  Liu,  MD,  PhD,  Hematopathologist,  Emerge    10:10-­‐10:40     Biomarkers  and  precision  therapy  for  sarcoma         Ping  Chi,  MD,  PhD,  Geoffrey  Beene  Junior  Faculty  Chair,  MSKCC,  NY    10:40  -­‐11:00     Coffee  Break      Career  Development  and  Collaborations  Session  chairs:    Sen  Zhuang,  MD,  PhD.,  Vice  President,  Clinical  Oncology  Research,  J&J  Ruirong  Yuan,  MD,  PhD.  Chief    Medical  Officer,  Eisai  Global  Oncology      11:00  -­‐11:15     Career  in  pharmaceutical  industry           Sen  Zhuang,  MD,  PhD,  Vice  President,  Clinical  Oncology  Research,  J  &  J    11:15-­‐11:30   Collaboration  between  industry  and  academic  institution:  how  to  

make  it  a  WIN/WIN  situation     Ruirong  Yuan,  MD,  PhD,  Chief  Medical  Officer,  Eisai  Global  Oncology    11:30-­‐11:50   Oncology  practice  in  China:  opportunities  and  challenges     Jiping  Wang,  MD,  Assistant  Professor,  Harvard  University,  MA;    

Delong  Liu,  MD,  PhD,  Professor,  New  York  Medical  College,  NY      11:  50-­‐12:00     Coffee  Break      12:00-­‐12:45     Lunch  symposium      (independent  programs)                   Session  I  (Boardroom  East)         Session  Chair:    

Yuxia  Jia,  MD,  PhD,  Assistant  Professor,  Hershey    Medical  Center,  PA;           Speakers:    

Page 8: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

Eric  Liu,  MD,  Co-­‐Director,  Neuroendocrine  Center,  Surgical  Services,  Rocky  Mountain  Cancer  Centers,  Denver,  CO  

12:00-­‐  12:  20.  Neuroendocrine  Tumors  Clinical  Overview:  A  focus  on  2  Different  Types  of  Neuroendocrine  Tumors  (  NET)  and  Treatment  Options.    Zujun  Li,  MD.  Assistant  Professor,  NYU  Langone  Medical  Center,  NY     12:20-­‐12:40.    Key  Considerations  in  the  Frontline  Treatment  of  PH+CML,  5  years  of  clinical  trial  experience           Session  2  (Boardroom  West)         Session  Chair:  Zili  He,  MD,  PhD,  Hematology  /Oncology,  Flushing,  NY         Speaker:    Shuo  Ma,  MD,  PhD,  Assistant  Professor,  Feinberg  Shool  of  Medicine  and  Robert  H  Lurie  Comprehensive  Cancer  Center,  Northwestern  University,  Chicago,  IL  

Imbruvica  (Ibrutinib):  single  agent  therapy  for  previously  treated  chronic  lymphoid  leukemia  and  del  17p  CLL    

Session  3  (Phenix  Ballroom)         Session  Chair:  Peter  Yu,  MD,  Immediate-­‐past  ASCO  President  

Speaker:    Jiping  Wang,  MD,  Assistant  Professor,  Brigham  &  Women’s  Hospital,  Harvard  University  

Oncology  care  in  Shanghai-­‐  an  overview  of  the  new  Jiahui  International  Hospital                    Simultaneous  sessions    Hematology  and  Oncology    Session  chairs:    Richard  Xu,  MD,  PhD,  Hematologist  &  Oncologist,  Flushing,  NY;    Lihong  Wei,  MD,  Hematologist  &  Oncologist,  Flushing,  NY  Shenhong  Wu,  MD,  Clinical  Associate  Professor,  SUNY  Stony  Brook  Cancer  Center,  NY                    1:00–1:15     Novel  agents  for  lung  cancer           Tianhong  Li,  MD,  PhD,    Associate  Professor,  UC  Davis          

   1:15-­‐1:30     Novel  agents  for  Breast  cancer         Chau  Dang,  MD,  Chief,  MSKCC  Harrison  Branch,  NY    1:30-­‐1:45     Novel  agents  for  Head  and  Neck  cancer        

Page 9: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

      Yifan  Tu,  MD,  PhD,  Assistant  Professor,  St.  Louis  University,  MO      1:45-­‐2:00     Prostate  cancer  update  

Che-­‐Kai  Tsao,  MD,  Assistant  Professor,  Department  of  Hematology  /Oncology,  Mt  Sinai  Medical  Center,  NY  

   2:00-­‐2:30     Coffee  Break          Simultaneous  sessions    Molecular  Diagnosis,  and  Precision  Therapy                Session  chairs:    William  Li,  MD,  Director  of  Radiation  Oncology,  Queens  Hospital  Center,  NY  Min  Sun,  MD,  PhD,  Clinical  Assistant  Professor,  University  of  Pittsburgh  Medical  Center,  PA  Ping  Gu,  MD.  Assistant  Professor,  Division  of  Oncology,  NYU  Langone  Medical  Center,  NY;          1:00–1:30     Biomarkers  for  cancer  immunotherapy  

Jianda  Yuan,  PhD,  Memorial  Sloan  Kettering  Cancer  Center,  NY            

     1:30-­‐2:00     Precision  therapy  with  Radiation      

Baoqing  Li,  MD,  Assistant  Professor  of  Clinical  Radiation  Oncology,  Weill  Cornell  Medical  College  and  New  York  Hospital  of  Queens,  Flushing,  NY  

   2:00-­‐2:30   Coffee  Break                Plenary  session    2:30-­‐3:30     Oncology  practice  advisory  board  

1. Tumor  Board  and  case  discussion  2. International  consulting  on  patients  from  China  

 Session  chairs:    

Page 10: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

Gary  Guo,  MD,  PhD,  ACAP  President;  Attending  physician,  Westchester  Medical  Center,  NY  

Jeffrey  Ye,  MD,  PhD,  Kaiser,  San  Francisco  David  Chang,  MD,  PhD,  Associate  Professor,  Eastern  Virginia  

Medical  School;  Janice  Lu,  MD,  PhD,  Associate  Professor,  Division of

Hematology and Oncology, David Geffen School of Medicine, UCLA      Panelists:    

   Lan  Mo,  MD,  PhD,  Assistant  Professor,  Weill  Cornell  Medical  

College,  NY  Mei  Tang,  MD.    Med  Oncology,  Baltimore,  MD  Yue  Zhang,  MD,  Assistant  Professor,  SUNY  Stony  Brook,  NY  

   3:30-­‐4:00   Medical  Education  and  Training:  residency,  fellowship,  clinical  trials        

Session  chairs      

Chung-­‐tsen  Hsueh,  MD,  PhD,  Associate  Professor  of  Medicine,  Fellowship  Program  Director  of  Loma  Linda  University,  LA  Yiwu  Huang,  MD,  PhD,  Fellowship  Director,  Maimonides  Med  Center,  NY  Yupo  Ma,  MD,  PhD,  Professor  of  Pathology,  Director  of  Flowcytometry  Laboratory,  SUNY  Stonybrook  Medical  Center,  NY  Yiqing  Xu,  MD,  Associate  Professor,  Director  of  Clinical  Research,  Maimonides  Cancer  Center,  NY  Lanjing  Zhang,  MD,  PhD.  Director  of  GI  Pathology,  Robert  Wood  Johnson,  NJ  

     4:00     Conclusion  and  adjourn       Delong  Liu            

Page 11: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

 

   

CAHON  Annual  Meeting    &    

Award  Ceremony  By  invitation  only  

 6:00  to  10:00pm  

October  3,  2015,  Saturday  Galleria  Conference  Room  Sheraton  La  Guardia  East  Flushing,  NY  11355    

Page 12: 9-9-2015 agenda for 10-3-2015 NY Onc Forum › UserFiles › file › 9-9-2015... · 9:40>9:55’ ’ Novel’agentsformyeloproliferative’neoplasm’ ’ ’ ’ ’ ’ ’ HongtaoLiu,’MD,’PhD,’Assistant’Professor,’University’of

New  York  Oncology  Forum  Registration  Form  

 Name:  Last  Name______________________,  First  Name____________________    Institution________________________________________________________________    Email:____________________________________________________________________    Office  Phone:  ___________________________________________________________      Registration  fee:  $100  (make  check  payable  to  Chinese  American  

Hematologist  Oncologist  Network);    Please  mail  the  check  to:  CAHON,  c/o  Delong  Liu,  441  Central  Park  Avenue  #1308,  Scarsdale,  NY  10583.  The  fee  is  waived  for  the  members  of  CAHON  and  ACAP,  conference  faculties,  and  for  trainees  (students,  residents  and  fellows).